By Cian Muenster and Bartosz Dabrowski

(Reuters) -Swiss dental implant maker Straumann reported an 8.3% rise in third-quarter organic sales on Wednesday, slightly above market expectations, as growth in most Asia-Pacific markets and North America outweighed muted demand in China.

Revenue climbed to 602.2 million Swiss francs ($759.3 million) in the July-September period, compared with analysts’ estimate of 600.6 million Francs in a Vara consensus.

Shares of the company rose 5.8% to 92.86 francs post results.

The company’s Asia Pacific sales came in at 144.3 million francs, below consensus estimates of 151.5 million francs. The region accounts for about a quarter of Straumann’s total sales.

The company said its revenue in China has begun to soften as patients delay treatment and distri

See Full Page